In today’s global economy, the fight against financial crime is more critical than ever. Anti-Money Laundering (AML) certifications are essential for professionals seeking to advance their careers in ...

Olutasidenib shows sustained efficacy and manageable safety in relapsed/refractory mutant IDH1 acute myeloid leukemia, with a 35% complete remission rate and 48% overall response rate. Patients with ...

The overall 5-year relative survival rate for AML is about 30%, but this number is an estimate based on a large group of people and does not predict individual outcomes. Younger people with AML tend ...

Secondary acute myeloid leukemia (AML) is a blood cancer that arises from other blood disorders or previous cancer treatment. Those with secondary AML tend to have a less favorable outlook than those ...

Money laundering is a massive global problem estimated at 2-5% of global GDP (up to $2 trillion annually). In response to the ...